Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Constanze Uhlmann

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Current Protocols in Stem Cell Biology|December 29, 2019
Efficient Modulation of TP53 Expression in Human Induced Pluripotent Stem CellsConstanze Uhlmann, Lisa-Maria Kuhn, Julia Tigges, et al.
Molecular Plant Pathology|August 10, 2016
Signatures of selection and host-adapted gene expression of the Phytophthora infestans RNA silencing suppressor PSR2Sophie de Vries, Janina K von Dahlen, Constanze Uhlmann, et al.
Pharmaceuticals (Basel, Switzerland)|September 28, 2021
Testing the Stability of Drug Resistance on Cryopreserved, Gene-Engineered Human Induced Pluripotent Stem CellsDilaware Khan, Ann-Christin Nickel, Sebastian Jeising, et al.
Oncotarget|June 2, 2018
Inhibition of Wnt/beta-catenin signaling downregulates expression of aldehyde dehydrogenase isoform 3A1 (ALDH3A1) to reduce resistance against temozolomide in glioblastoma <i>in vitro</i>Abigail Kora Suwala, Katharina Koch, Dayana Herrera Rios, et al.
Cell Death Discovery|April 28, 2020
A comparative pharmaco-metabolomic study of glutaminase inhibitors in glioma stem-like cells confirms biological effectiveness but reveals differences in target-specificityKatharina Koch, Rudolf Hartmann, Julia Tsiampali, et al.
Biotechnology Journal|March 25, 2022
Progenitor cells derived from gene-engineered human induced pluripotent stem cells as synthetic cancer cell alternatives for in vitro pharmacologyConstanze Uhlmann, Ann-Christin Nickel, Daniel Picard, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Current Protocols in Stem Cell Biology|December 29, 2019
Efficient Modulation of TP53 Expression in Human Induced Pluripotent Stem CellsConstanze Uhlmann, Lisa-Maria Kuhn, Julia Tigges, et al.
Molecular Plant Pathology|August 10, 2016
Signatures of selection and host-adapted gene expression of the Phytophthora infestans RNA silencing suppressor PSR2Sophie de Vries, Janina K von Dahlen, Constanze Uhlmann, et al.
Pharmaceuticals (Basel, Switzerland)|September 28, 2021
Testing the Stability of Drug Resistance on Cryopreserved, Gene-Engineered Human Induced Pluripotent Stem CellsDilaware Khan, Ann-Christin Nickel, Sebastian Jeising, et al.
Oncotarget|June 2, 2018
Inhibition of Wnt/beta-catenin signaling downregulates expression of aldehyde dehydrogenase isoform 3A1 (ALDH3A1) to reduce resistance against temozolomide in glioblastoma <i>in vitro</i>Abigail Kora Suwala, Katharina Koch, Dayana Herrera Rios, et al.
Cell Death Discovery|April 28, 2020
A comparative pharmaco-metabolomic study of glutaminase inhibitors in glioma stem-like cells confirms biological effectiveness but reveals differences in target-specificityKatharina Koch, Rudolf Hartmann, Julia Tsiampali, et al.
Biotechnology Journal|March 25, 2022
Progenitor cells derived from gene-engineered human induced pluripotent stem cells as synthetic cancer cell alternatives for in vitro pharmacologyConstanze Uhlmann, Ann-Christin Nickel, Daniel Picard, et al.
Pageof 1